VOYA Investment Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.8M Sell
63,993
-608
-0.9% -$83.6K 0.01% 767
2025
Q1
$11.6M Sell
64,601
-10,100
-14% -$1.82M 0.01% 691
2024
Q4
$11.7M Buy
74,701
+4,123
+6% +$646K 0.01% 702
2024
Q3
$12.8M Sell
70,578
-4,174
-6% -$760K 0.01% 690
2024
Q2
$13.7M Buy
74,752
+14,027
+23% +$2.58M 0.01% 659
2024
Q1
$10.8M Buy
60,725
+13,128
+28% +$2.34M 0.01% 731
2023
Q4
$5.9M Buy
47,597
+19,157
+67% +$2.38M 0.01% 938
2023
Q3
$3.3M Sell
28,440
-12,900
-31% -$1.5M ﹤0.01% 1136
2023
Q2
$4.85M Buy
41,340
+8,186
+25% +$961K 0.01% 1005
2023
Q1
$2.65M Sell
33,154
-29,455
-47% -$2.36M ﹤0.01% 1236
2022
Q4
$4.96M Sell
62,609
-1,577
-2% -$125K 0.01% 965
2022
Q3
$4.47M Buy
64,186
+56,408
+725% +$3.93M 0.01% 1001
2022
Q2
$511K Buy
7,778
+766
+11% +$50.3K ﹤0.01% 1826
2022
Q1
$467K Hold
7,012
﹤0.01% 1957
2021
Q4
$490K Sell
7,012
-49,223
-88% -$3.44M ﹤0.01% 2028
2021
Q3
$2.94M Sell
56,235
-4,280
-7% -$223K 0.01% 1020
2021
Q2
$4.12M Sell
60,515
-29,555
-33% -$2.01M 0.01% 934
2021
Q1
$6.94M Sell
90,070
-14,213
-14% -$1.09M 0.01% 721
2020
Q4
$6.26M Sell
104,283
-8,190
-7% -$491K 0.01% 740
2020
Q3
$4.84M Buy
112,473
+21,661
+24% +$933K 0.01% 763
2020
Q2
$3.76M Buy
90,812
+19,017
+26% +$788K 0.01% 840
2020
Q1
$3.1M Sell
71,795
-9,351
-12% -$404K 0.01% 827
2019
Q4
$4.49M Sell
81,146
-118,005
-59% -$6.53M 0.01% 840
2019
Q3
$6.92M Buy
+199,151
New +$6.92M 0.02% 707